Endoscopic Spinal Surgery Market By Product Type, By Procedure type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The global endoscopic spinal surgery market was valued at $536.9 million in 2021, and is projected to reach $1,096.31 million by 2031, registering a CAGR of 7.4% from 2022 to 2031.

Endoscopic spinal surgery (ESS) is referred to surgical procedure, which utilizes a micro-sized incisions which is less than 1-inch and a small tubular system together with an endoscope to get clear image of the internal organs of the human body. This type of spinal surgeries has now become a choice of treatment for many patients owing to the advances in optics, high quality visualization of tissues, and efficient spinal imaging that is offered by ESS. In addition, this procedure is one of the minimally invasive surgeries that provide patients fastest recovery after the surgery. Furthermore, the surgery involves use of tubular retractors and endoscope, which allows indirect visualization of the internal organs. In addition, indirect visualization during procedures has been replaced the traditional forms of direct visualization across many different surgical specialties, which further increases demand for endoscopic spinal surgery.

According to the World Health Organization (WHO), in 2030, it is anticipated there will be about 1 billion older people worldwide, which is equivalent to 12% of the total population. The share of geriatric population is anticipated to continue to grow in the following 20 years. By 2050, it is estimated that there will be 1.6 billion older people worldwide, representing 16.7% of the total world population of 9.4 billion. In addition, according to several studies, it is reported that geriatric population is more prone to several age-related chronic illnesses such as lower back pain and spinal arthritis that may require special treatment procedures.

This anticipated rise in the number of aged population propel demand for endoscopic spinal surgeries as the treatment option as it is less painful and offers faster recovery, which further leads to expansion of the market during the forecast period.

In addition, there is a rise in cases of the spinal disorders such as ankylosing spondylitis, spinal stenosis, herniated discs, hematoma, degenerative disc disease, vertebral fractures and others. According to the Johns Hopkins Arthritis Center, in the recent population estimates indicate that the prevalence of ankylosing spondylitis (AS) in the U.S. is approximately 0.2-0.5% and based on data from multiple countries, the age- and sex-adjusted incidence of ankylosing spondylitis (AS) is 0.4-14 per 100,000 people. In addition, in a year about 2% of people get a herniated disk. Thus, there is a huge prevalence of spinal disorders around the globe, which also increases demand for endoscopic spinal surgery, thereby boosting adoption of instruments associated with the surgery. This further propels growth of the endoscopic spinal surgery market.

Furthermore, technological advancements in this field have led to increase in adoption of this technique among the healthcare providers and also by the patients. Complexity of spinal surgery causes serious obstacles during the procedure, and can lead to less effective surgery, therefore, to overcome this, huge technological advances have been made by researchers. Moreover, use of 3D endoscopes have reduced the risk of damage and enhanced accuracy of the procedure. For instance, introduction of a highly precise procedure for endoscopic spinal surgery with the combination of four key technologies including 3D analysis, advanced algorithms, patient connection platform, and cross modality image registration developed by Mazor Robotics. In addition, governments and other organizations provide fundings to initiate research and development activities in certain regions to bring development in healthcare facilities. This also accelerates growth of the market.

In addition, factors such as rise in adoption of minimally invasive spinal surgeries, increase in prevalence of spinal disorders, and increase in geriatric population around the globe propel growth of the market. Although there are many factors driving growth of the market, high cost associated with endoscopic spine surgery and lack of adequate reimbursement policies in emerging regions hampers growth of the market.

The endoscopic spinal surgery market is studied on the basis of product type, procedure type, end user, and region. By product type, the market is segmented into endoscopes and endoscopic devices. By procedure type, transforaminal endoscopic procedures, interlaminar endoscopic procedures, endoscopic posterior foraminotomy & cervical discectomy and endoscopic visualized rhizotomy. By end user, it is classified into hospitals & clinics and ambulatory surgical centers. Region wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include Endovision Co. Ltd, Globus Medical Inc., Jiomax Inc., Johnson & Johnson (Depuy Synthes Spine, Inc.), Karl Storz Se & Co. Kg, Medtronic Plc., Medicaltek Co., Ltd., Olympus Corporation, Richard Wolf, Stryker Corporation, and Zimmer Biomet Holdings, Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the endoscopic spinal surgery market analysis from 2021 to 2031 to identify the prevailing endoscopic spinal surgery market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the endoscopic spinal surgery market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global endoscopic spinal surgery market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

Endoscopes
Endoscopic Devices

By Procedure type

Transforaminal Endoscopic Procedures
Interlaminar Endoscopic Procedures
Endoscopic Posterior Foraminotomy and Cervical Discectomy
Endoscopic Visualized Rhizotomy

By End User

Hospital and Clinics
Ambulatory Surgical Centers

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
- MEDTRONIC PLC.
- MEDICALTEK CO., LTD.
- STRYKER CORPORATION
- ZIMMER BIOMET HOLDINGS, INC.
- OLYMPUS CORPORATION
- KARL STORZ SE & CO. KG
- Richard Wolf GmbH
- GLOBUS MEDICAL INC.
- Endovision Co., Ltd.
- joimax GmbH

Product Code: A31581

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Endoscopes
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
4.3 Endoscopic Devices
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country

CHAPTER 5: ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Transforaminal Endoscopic Procedures
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
5.3 Interlaminar Endoscopic Procedures
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
5.4 Endoscopic Posterior Foraminotomy and Cervical Discectomy
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
5.5 Endoscopic Visualized Rhizotomy
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market share analysis by country

CHAPTER 6: ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Hospital and Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
6.3 Ambulatory Surgical Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country

CHAPTER 7: ENDOSCOPIC SPINAL SURGERY MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product Type
- 7.2.3 North America Market size and forecast, by Procedure type
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Key market trends, growth factors and opportunities
  - 7.2.5.1.2 Market size and forecast, by Product Type
  - 7.2.5.1.3 Market size and forecast, by Procedure type
  - 7.2.5.1.4 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Key market trends, growth factors and opportunities
  - 7.2.5.2.2 Market size and forecast, by Product Type
  - 7.2.5.2.3 Market size and forecast, by Procedure type
  - 7.2.5.2.4 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Key market trends, growth factors and opportunities
  - 7.2.5.3.2 Market size and forecast, by Product Type
  - 7.2.5.3.3 Market size and forecast, by Procedure type
  - 7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product Type
- 7.3.3 Europe Market size and forecast, by Procedure type
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Key market trends, growth factors and opportunities
  - 7.3.5.1.2 Market size and forecast, by Product Type
  - 7.3.5.1.3 Market size and forecast, by Procedure type
  - 7.3.5.1.4 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Key market trends, growth factors and opportunities
  - 7.3.5.2.2 Market size and forecast, by Product Type
  - 7.3.5.2.3 Market size and forecast, by Procedure type
  - 7.3.5.2.4 Market size and forecast, by End User
  - 7.3.5.3 UK
  - 7.3.5.3.1 Key market trends, growth factors and opportunities
  - 7.3.5.3.2 Market size and forecast, by Product Type
  - 7.3.5.3.3 Market size and forecast, by Procedure type
  - 7.3.5.3.4 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Key market trends, growth factors and opportunities
  - 7.3.5.4.2 Market size and forecast, by Product Type
  - 7.3.5.4.3 Market size and forecast, by Procedure type
  - 7.3.5.4.4 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Key market trends, growth factors and opportunities
  - 7.3.5.5.2 Market size and forecast, by Product Type
  - 7.3.5.5.3 Market size and forecast, by Procedure type
  - 7.3.5.5.4 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Key market trends, growth factors and opportunities
  - 7.3.5.6.2 Market size and forecast, by Product Type
  - 7.3.5.6.3 Market size and forecast, by Procedure type
  - 7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product Type
- 7.4.3 Asia-Pacific Market size and forecast, by Procedure type
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Key market trends, growth factors and opportunities
  - 7.4.5.1.2 Market size and forecast, by Product Type
  - 7.4.5.1.3 Market size and forecast, by Procedure type
  - 7.4.5.1.4 Market size and forecast, by End User
  - 7.4.5.2 China
  - 7.4.5.2.1 Key market trends, growth factors and opportunities
  - 7.4.5.2.2 Market size and forecast, by Product Type
  - 7.4.5.2.3 Market size and forecast, by Procedure type
  - 7.4.5.2.4 Market size and forecast, by End User
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Key market trends, growth factors and opportunities
  - 7.4.5.3.2 Market size and forecast, by Product Type
  - 7.4.5.3.3 Market size and forecast, by Procedure type
  - 7.4.5.3.4 Market size and forecast, by End User
  - 7.4.5.4 India
  - 7.4.5.4.1 Key market trends, growth factors and opportunities
  - 7.4.5.4.2 Market size and forecast, by Product Type
  - 7.4.5.4.3 Market size and forecast, by Procedure type
  - 7.4.5.4.4 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Key market trends, growth factors and opportunities
  - 7.4.5.5.2 Market size and forecast, by Product Type
  - 7.4.5.5.3 Market size and forecast, by Procedure type
  - 7.4.5.5.4 Market size and forecast, by End User
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Key market trends, growth factors and opportunities
  - 7.4.5.6.2 Market size and forecast, by Product Type
  - 7.4.5.6.3 Market size and forecast, by Procedure type
  - 7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product Type
- 7.5.3 LAMEA Market size and forecast, by Procedure type
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Key market trends, growth factors and opportunities
  - 7.5.5.1.2 Market size and forecast, by Product Type
  - 7.5.5.1.3 Market size and forecast, by Procedure type
  - 7.5.5.1.4 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Key market trends, growth factors and opportunities
  - 7.5.5.2.2 Market size and forecast, by Product Type
  - 7.5.5.2.3 Market size and forecast, by Procedure type
  - 7.5.5.2.4 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Key market trends, growth factors and opportunities
  - 7.5.5.3.2 Market size and forecast, by Product Type
  - 7.5.5.3.3 Market size and forecast, by Procedure type
  - 7.5.5.3.4 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Key market trends, growth factors and opportunities
  - 7.5.5.4.2 Market size and forecast, by Product Type
  - 7.5.5.4.3 Market size and forecast, by Procedure type
  - 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 MEDTRONIC PLC.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 MEDICALTEK CO., LTD.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 STRYKER CORPORATION
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 ZIMMER BIOMET HOLDINGS, INC.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 OLYMPUS CORPORATION
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 KARL STORZ SE & CO. KG
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Richard Wolf GmbH
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 GLOBUS MEDICAL INC.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 Endovision Co., Ltd.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
9.11 joimax GmbH
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments